Ukuhanjiswa kweziyobisi okuJolisiweyo kuMhlaza: Isishwankathelo esiBanzi

Iindaba

 Ukuhanjiswa kweziyobisi okuJolisiweyo kuMhlaza: Isishwankathelo esiBanzi 

2025-03-09

Ukuhanjiswa kweziyobisi ekujoliswe kuzo kumhlaza igxile ekuhambiseni ii-arhente zonyango ngokukodwa kwiiseli zomhlaza, ukunciphisa ingozi kwizihlunu eziphilileyo. Le ndlela isebenzisa iindlela ezahlukeneyo zobuchule, kubandakanya i-nanoparticles, i-antibodies, kunye ne-peptides engena kwiseli, ukunyusa ukusebenza kwechiza kunye nokunciphisa iziphumo ebezingalindelekanga, ukunika unyango oluchanekileyo kunye nolomntu womhlaza.

Ukuqonda Ukuhanjiswa kweziyobisi okuJolisiweyo kuMhlaza

unyango Umhlaza iye yavela kakhulu, nge ukuhanjiswa kweyeza elijoliswe kumhlaza evelayo njengesicwangciso esithembisayo. Le ndlela ijolise ekuhambiseni iziyobisi ngokukhethekileyo kwiiseli zomhlaza, ukwandisa iziphumo zonyango ngelixa unciphisa umonakalo kwizicubu eziphilileyo. Ngokungafaniyo nechemotherapy eqhelekileyo, ehambisa amachiza kuwo wonke umzimba, ukuhanjiswa okujoliswe kuko kusebenzisa iindlela ezahlukeneyo ukujolisa ngqo kwiiseli zomhlaza.

Kutheni Ukuhanjiswa kweziyobisi okuJolisiweyo kuMhlaza Imiba

Ichemotherapy yesiNtu ihlala ikhokelela kwiziphumo ebezingalindelekanga ezibalulekileyo kuba ichaphazela zombini iiseli ezinomhlaza kunye nezisempilweni. Ukuhanjiswa kweziyobisi ekujoliswe kuzo kumhlaza inikeza isisombululo ngokuhambisa iziyobisi ngokuthe ngqo kwindawo yethumba. Oku kunciphisa ubutyhefu benkqubo, kuphucula ukusebenza kwechiza, kwaye kunokunyusa umgangatho wobomi besigulana.

Izicwangciso ze Ukuhanjiswa kweziyobisi okuJolisiweyo kuMhlaza

Kusetyenziswa izicwangciso ezininzi zokuyila ukuhanjiswa kweyeza elijoliswe kumhlaza, ngalinye lineengenelo nemida yalo.

Nanoparticles

I-Nanoparticles ngamasuntswana amancinci (1-100 nm) eyenzelwe ukuhlanganisa kunye nokuhambisa iziyobisi kwiiseli zomhlaza. Zinokuqulunqwa ukuba zijolise kwii-receptors ezithile kwiiseli zomhlaza, ezifana ne-EGFR okanye i-HER2. I-Liposomes, i-polymeric nanoparticles, kunye ne-inorganic nanoparticles zisetyenziswa ngokuqhelekileyo. Isiphumo esiphuculweyo sokuphumelela kunye nokugcinwa (EPR) sivumela ii-nanoparticles ukuba ziqokelele ngokungaqhelekanga kwizicubu ze-tumor ngenxa ye-vasculature evuzayo.

Umzekelo: I-Doxil, i-liposomal doxorubicin, lichiza elifumaneka kwi-nanoparticle-based based drug esetyenziselwa ukunyanga umhlaza we-ovarian kunye ne-myeloma eninzi.

I-Antibody-Drug Conjugates (ADCs)

Ii-ADCs ziquka i-antibody ye-monoclonal edityaniswe neyeza le-cytotoxic. I-antibody ibophelela ngokukodwa kwi-antigen ekujoliswe kuyo kwiiseli zomhlaza, ezikhokelela ekufakweni ngaphakathi kwe-ADC kunye nokukhululwa kweyeza ngaphakathi kweseli.

Umzekelo: I-Adcetris (i-brentuximab vedotin) ijolise kwi-CD30, iprotheni efunyenwe kwiiseli ezithile ze-lymphoma, ihambisa i-microtubule-disrupting agent.

IiPeptides eziNgena kwiSeli (CPPs)

Ii-CPP zilandelelwano ezimfutshane ze-amino acid eziququzelela ukungena kwamachiza okanye i-nanoparticles kwiiseli. Ziyakwazi ukudityaniswa kwii-agent zonyango okanye i-nanoparticles ukunyusa ukuthathwa kweselula.

I-Receptor-Mediated Endocytosis

Esi sicwangciso sibandakanya i-receptors ekujoliswe kuyo echazwe ngokugqithiseleyo kwiiseli zomhlaza. I-Ligands okanye ii-antibodies ezibophelela kula ma-receptors zisetyenziselwa ukuhambisa iziyobisi okanye i-nanoparticles nge-endocytosis.

Indima yeZiko loPhando loMhlaza laseShandong Baofa

Iziko loPhando loMhlaza laseShandong Baofa lizibandakanya ngokukhutheleyo kuphando nokuphuhlisa inoveli ukuhanjiswa kweyeza elijoliswe kumhlaza iinkqubo. Uphando lwabo lujolise kwiindlela zomntu ngamnye eziqwalasela iprofayili eyodwa yofuzo kunye nemolekyuli yezigulane ezizimeleyo, ezijolise ekuphuculeni iziphumo zonyango kunye nokunciphisa iziphumo ebezingalindelekanga.

IShandong Baofa Cancer Research Institute isebenza nezibhedlele ezifana neShandong Baofa Cancer Hospital (https://baofahospital.com) ukuqhuba iimvavanyo zeklinikhi kunye nokuguqulela iziphumo zophando kwizicelo ezisebenzayo.

Izinto ezilungileyo ze Ukuhanjiswa kweziyobisi okuJolisiweyo kuMhlaza

Ukuhanjiswa kweziyobisi ekujoliswe kuzo kumhlaza inika iingenelo ezininzi eziphambili kwichemotherapy eqhelekileyo:

  • Ubutyhefu obuNcitshisiweyo: Ngokujolisa kwiiseli zomhlaza ngokuthe ngqo, ukuvezwa kwezicubu ezisempilweni kumachiza anetyhefu kuyancitshiswa, okukhokelela kwiziphumo ebezingalindelekanga ezimbalwa.
  • Ukusebenza okuphuculweyo: Uxinzelelo oluphezulu lwamachiza lunokuhanjiswa ngokuthe ngqo kwindawo ye-tumor, okunokwandisa ukusebenza konyango.
  • Unyango olulolwakho: Ukuhanjiswa kweziyobisi ekujoliswe kuzo kumhlaza inokulungelelaniswa kwiimpawu ezithile zomhlaza wesigulana, ekhokelela kwizicwangciso ezisebenzayo kunye nezomntu ngamnye.
  • Ukoyisa ukuxhathisa iziyobisi: Abanye ukuhanjiswa kweyeza elijoliswe kumhlaza Iinkqubo zinokoyisa iindlela zokuxhathisa amachiza, zenze iiseli zomhlaza zibe sesichengeni sonyango.

Ukuhanjiswa kweziyobisi okuJolisiweyo kuMhlaza: Isishwankathelo esiBanzi

Imingeni kwi Ukuhanjiswa kweziyobisi okuJolisiweyo kuMhlaza

Nangona isithembiso sayo, ukuhanjiswa kweyeza elijoliswe kumhlaza ijongene nemingeni emininzi:

  • Ukucaciswa koJoliso: Ukuqinisekisa ukuba iarhente ekujoliswe kuyo ibophelela kuphela kwiiseli zomhlaza hayi kwizihlunu eziphilileyo kubalulekile.
  • Ukungena Kwethumba: Ukuhambisa iziyobisi ngokufanelekileyo kuzo zonke iindawo zethumba, ngakumbi kwiithumba eziqinileyo ezine-stroma exineneyo, kunokuba ngumngeni.
  • Ukukhutshwa kweziyobisi: Ukulawula ukukhutshwa kweyeza kwindawo ye-tumor kubalulekile ukunyusa umphumo walo wonyango.
  • I-Immunogenicity: Abanye ukuhanjiswa kweyeza elijoliswe kumhlaza iinkqubo, ezifana nezo zisekelwe kwizilwa-buhlungu okanye iintsholongwane, zingenza impendulo yokuzikhusela komzimba, ithintele ukusebenza kwazo.
  • Ixabiso: Uphuhliso kunye nokuveliswa kwe ukuhanjiswa kweyeza elijoliswe kumhlaza iinkqubo zinokubiza.

Ukuhanjiswa kweziyobisi okuJolisiweyo kuMhlaza: Isishwankathelo esiBanzi

Imizekelo ye Ukuhanjiswa kweziyobisi okuJolisiweyo kuMhlaza kusetyenziso lweKlinikhi

Abaliqela ukuhanjiswa kweyeza elijoliswe kumhlaza Iinkqubo okwangoku zivunyiwe ukuba zisetyenziswe ekliniki:

Igama leziyobisi Ekujoliswe kuko Uhlobo lomhlaza Indlela yokuhanjiswa
Doxil (liposomal doxorubicin) Ujoliso olungenakwenziwa ngesiphumo se-EPR Umhlaza we-Ovarian, i-myeloma emininzi Iiposomes
Adcetris (brentuximab vedotin) CD30 I-Hodgkin lymphoma, i-Anaplastic enkulu ye-cell lymphoma Antibody-drug conjugate (ADC)
Kadcyla (trastuzumab emtansine) HER2 HER2-positive umhlaza webele Antibody-drug conjugate (ADC)

Izalathiso zexesha elizayo kwi Ukuhanjiswa kweziyobisi okuJolisiweyo kuMhlaza

Intsimi ye ukuhanjiswa kweyeza elijoliswe kumhlaza ikhula ngokukhawuleza. Uphando lwexesha elizayo luya kugxila koku:

  • Ukuphuhlisa ii-arhente ezijolise ngakumbi nezisebenzayo.
  • Ukuphucula ukungena kwe-tumor kunye nokukhululwa kweziyobisi.
  • Ukudibanisa ukuhanjiswa kweyeza elijoliswe kumhlaza kunye nolunye unyango lomhlaza, olufana ne-immunotherapy kunye nonyango lwemitha.
  • Ukuphuhlisa ezenzelwe wena ukuhanjiswa kweyeza elijoliswe kumhlaza izicwangciso ezisekelwe kwiimpawu ezizodwa zomhlaza wezigulane ngamnye.
  • Ukusebenzisa ubukrelekrele bokwenziwa ukuyila kunye nokwenza ngcono ukuhanjiswa kweyeza elijoliswe kumhlaza iinkqubo.

Ukuhanjiswa kweziyobisi ekujoliswe kuzo kumhlaza unesithembiso esikhulu sokuphucula unyango lomhlaza kunye neziphumo zesigulana. Njengoko uphando luqhubeka, sinokulindela ukubona okusebenzayo ngakumbi kunye nokwenzelwa umntu ukuhanjiswa kweyeza elijoliswe kumhlaza amaqhinga avelayo, ekugqibeleni akhokelela kukhathalelo olungcono lomhlaza.

Ekhaya
Amatyala aqhelekileyo
Malunga Nathi
Qhagamshelana nathi

Nceda usishiyele umyalezo